Vickers Venture SPAC to merge with subsidiary of Sorrento Therapeutics
Singapore
VICKERS Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company, a commercial biopharmaceutical company focused on developing and commercialising non-opioid therapies for patients with acute and chronic pain.
Scilex Holding is a subsidiary of pharma giant Sorrento Therapeutics, which is also listed on the Nasdaq.
TRENDING NOW
From legacy to launch: Francis Yeoh and Yeoh Pei Xien on family unity and YTL’s next‑gen ventures
Things to know about DBS’ incoming chairman Anthony Lim
Wealthy Indonesians snap up government bonds as yields near 8%: OCBC
From local AI partnerships to global opportunities: How MNCs help Singapore firms scale